MelaFind

Ground-Breaking Melanoma Detection Device Now Available

We are proud to announce the introduction of MelaFind into our practice. MelaFind, developed by MELA Sciences and recently approved by the FDA, is a brand new medical technology that is used during a skin exam to help dermatologists see under the skin’s surface. The device collects information from 2.5 mm deep into the skin painlessly and non-invasively using computer vision technology, providing dermatologists with a clinically validated, objective system to help in deciding whether or not to biopsy irregular moles for detecting early-stage melanoma.

• MelaFind is the world’s first and only multi-spectral, non-invasive, painless and 100% objective and automated computer vision technology that evaluates clinically atypical pigmented skin lesions and classifies them unambiguously and clearly based upon their level of 3-dimensional morphological disorganization.
• The safety and effectiveness of MelaFind was established in the largest prospective clinical study in melanoma detection ever conducted.
• MelaFind works by acquiring multi-spectral digital data from a clinically atypical PSL using 10 distinct wavelengths, invoking proprietary data processing algorithms for automatic analysis, and providing unambiguous output based on the level of 3-dimensional morphological disorganization of the lesion.